Received 06/21/2022 review began 08/06/2022 review ended 09/08/2022 published 09/13/2022

HIGHLIGHTS

• who: Venlafaxine et al. from the California Institute of Behavioral Neurosciences and Psychology, USA Psychiatry and Behavioral Sciences have published the research: Received 06/21/2022 Review began 08/06/2022 Review ended 09/08/2022 Published 09/13/2022, in the Journal: (JOURNAL) of September/13,/2022
• what: The focus of the research is on the cardiovascular adverse effects of venlafaxine in post-MI depression.
• how: The search was performed using the MeSH strategy.

SUMMARY

And Background Major depression is a serious co-morbid condition in patients with . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.